Encyclopedia of AIDS (Encyclopedia of AIDS)
Editat de Thomas J. Hope, Douglas Richman, Mario Stevensonen Limba Engleză Carte Hardback – 22 Feb 2018
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Carte Hardback (1) | 4289.02 lei Economic 5-7 săpt. | |
| Springer – 22 Feb 2018 | 4289.02 lei Economic 5-7 săpt. | |
| Mixed media product (1) | 5940.85 lei Economic 3-5 săpt. | |
| Springer – March 2018 | 5940.85 lei Economic 3-5 săpt. |
Preț: 4289.02 lei
Preț vechi: 4514.76 lei
-5%
Puncte Express: 6434
Preț estimativ în valută:
854.74€ • 949.02$ • 728.02£
854.74€ • 949.02$ • 728.02£
Carte tipărită la comandă
Livrare economică 26 februarie-11 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781493971008
ISBN-10: 149397100X
Pagini: 1200
Dimensiuni: 178 x 254 mm
Greutate: 5.14 kg
Ediția: 1st ed. 2018
Editura: Springer
Colecția Springer
Seria Encyclopedia of AIDS
Locul publicării: New York, NY, United States
ISBN-10: 149397100X
Pagini: 1200
Dimensiuni: 178 x 254 mm
Greutate: 5.14 kg
Ediția: 1st ed. 2018
Editura: Springer
Colecția Springer
Seria Encyclopedia of AIDS
Locul publicării: New York, NY, United States
V-ar putea interesa
-
Concepts and Methods in Infectious Disease Surveillance Nkuchia M. M′ikanatha-5%Preț: 344.61 lei362.74 lei -
Infections of the Central Nervous System W. Michael Scheld MD-25%Preț: 1125.08 lei1500.09 lei -
Human Cytomegaloviruses: Methods and Protocols Andrew D. Yurochko-5%Preț: 593.82 lei625.08 lei -
-31%Preț: 1057.73 lei1532.94 lei -
-5%Preț: 274.96 lei289.43 lei -
Preț: 80.60 lei -
The End of Plagues John RhodesPreț: 179.34 lei -
Spillover David Quammen-13%Preț: 70.69 lei81.61 lei -
-5%Preț: 215.50 lei226.84 lei -
Infection & Immunity John Playfair-5%Preț: 284.10 lei299.05 lei -
Travel Medicine: Expert Consult - Online and Print Jay S. Keystone-5%Preț: 653.87 lei688.28 lei -
Vaccines: Expert Consult - Online and Print Stanley A. Plotkin-7%Preț: 1323.24 lei1422.84 lei -
-5%Preț: 902.00 lei949.47 lei -
Manual of Childhood Infections: The Blue Book Mike Sharland-6%Preț: 255.29 lei270.71 lei -
The Viral Storm: The Dawn of a New Pandemic Age Nathan D Wolfe-14%Preț: 67.19 lei78.05 lei -
Sexually Transmitted Diseases: Vaccines, Prevention, and Control Lawrence R. Stanberry-11%Preț: 629.72 lei707.54 lei -
Cytopathology of Infectious Diseases PANTANOWITZ LIRON-5%Preț: 480.69 lei505.98 lei
Cuprins
Abstinence,
Be
Faithful,
Condoms
(ABC),
Prevention
of
HIV.-
Acetylation.-
Actin.-
AIDS-related.-
Primary
Central
Nervous
System
Lymphoma.-
Anal
Cancer.-
Anatomic
Compartments
as
a
Barrier
to
HIV
Cure.-
Antiretroviral
Drug
Penetration
into
Lymphoid
Tissue.-
Antiretroviral
Drug
Penetration
into
the
CNS
Compartment.-
Antiretroviral
Medications,
Adult
Care
and
Treatment.-
Antiretroviral
therapy
(ART),
Prevention
of
HIV.-
Anti-Retroviral
Therapy
and
Drug
Resistance
in
HIV-2
Infection.-
Antiretroviral
Therapy
for
HIV-Infected
Infants,
Children,
and
Adolescents
in
Resource-Rich
Settings.-
Antiretroviral
Therapy:
When
to
Start.-
Antiretroviral
Treatment
in
Resource-Limited
Settings.-
APOBEC3F/G
and
Vif:
Action
and
Counteractions.- Apoptosis
Dysregulation
during
HIV
Disease.-Arp2/3.- Attachment/Binding.- Autophagy
and
HIV
Infection.- Bacterial
Respiratory
and
Invasive
Pneumococcal
Infections
and
HIV.- BAF
(BANF1).- Behavioral
Aspects
of
HIV
Mother-to-Child
Transmission.- Behavioral
Aspects
of
HIV
Treatment
as
Prevention.-
Behavioral
Interventions
for
Adherence.- Behavioral
Science
highlights
of
evidence
and
research.- Blood
and
blood
product
donors
and
recipients
in
China,
Epidemiology
of
HIV/AIDS.- Budding.- Burkitt
and
Burkitt-like
Lymphoma.- Cardiovascular
Complications.- cART
and
Supportive
Care
for
HIV-Associated
Malignancies.- Case
Management
for
Linkage.- Cell
Intrinsic
Immunity.- Cellular
and
Soluble
Immune
Activation
Markers
in
HIV-Infected
Subjects.- Cellular
Cofactors
for
HIV-1
Transcription.- Cellular
Cofactors
of
HIV
as
Drug
Targets.- Central
Memory
CD4
T
cells.- Cervical
Cancer
and
HIV.- Chagas
Disease
and
HIV.- Children,
Care
and
Treatment.- Children,
Epidemiology
of
HIV/AIDS.- Chronic
Immune
Activation
in
HIV.- Circumcision
and
AIDS.- Clinical
Ethics
in
HIV/AIDS
Prevention,
Care,
and
Research.- Cofilin,
Trafficking.- Collagen
Deposition
and
Fibrosis
in
the
Lymphatic
Tissues
of
HIV-1
Infected
Individuals.- Combination
Approaches
to
HIV
Prevention.- Community
Viral
Load.- Co-morbidity:
Opiods.- Comorbidity:
Progressive
Multifocal
Leukoencephalopathy.- Conjunctival
Carcinoma.- Counteraction
of
SAMHD1
by
Vpx.- Chromosome
Region
Maintenance
1
(CRM1).- Cryptococcosis
and
HIV.- Cryptosporidiosis.- Epidemic
Kaposi
Sarcoma,
Pathogenesis
and
Presentation
of
.- CXCR4,
Coreceptors.- Cyclophilin
A
and
HIV-1
Replication.- Cystoisosporiasis.- Cytomegalovirus
Infection
and
HIV.- DDX3,
Cofactors,
and
RNA
Export.- Delayed
Sexual
Debut.- Dendritic
Cell
Interactions
with
HIV-1
Envelope
Glycoprotein,
Implications
for
Preventing
Transmission.- Differential
Diagnosis
of
HIV-Associated
Neurocognitive
Disorders.- Diffuse
Large
B-Cell
Lymphoma.- Eastern
Europe
and
Central
Asia,
specific
characteristics
of
HIV/AIDS
epidemic.- Elderly:
Epidemiology
of
HIV/AIDS.- Entry
Inhibitors.- Epidemiology
of
AIDS-Defining
Malignancies.- Epidemiology
of
HIV-2
Infection
in
West
Africa.- Epidemiology
of
Non-AIDS-Defining
Malignancies.- Epstein
Barr
Virus
(EBV).- Faith
Based
Interventions.- Family
Interventions.- Female
Condoms.- Female,
Male
and
Transgender
Sex
Workers,
Epidemiology
of
HIV/AIDS.- Fusion.- Gamma
delta
T
cells.- Global
NeuroAIDS.- HAND
Adjunctive
Therapies:
Reversing
Neuronal
Injury.- Harm
Reduction
for
Injection
Drug
Users.- Health
care
workers,
Epidemiology
of
HIV/AIDS.- Health
care
workers,
Shortage
and
task
shifting
of.- Hepatitis
B
Virus
infection
and
HIV.- Hepatitis
C
Virus
Infection
and
HIV.- Hepatocellular
Carcinoma
in
HIV-Positive
Patients.- History
of
the
AIDS
epidemic.- HIV
"auxiliary"
proteins,
essential
role
of.- HIV
&
SIV,
CD4
T
cell
responses
to.- HIV
and
Opportunistic
Infections,
an
Overview.- HIV
and
Sexual
Violence.- HIV
and
SIV,
B-Cell
Responses
to.- HIV
and
SIV,
CD8
T
Cell
Responses
to.- HIV
Antigen
Processing
and
Presentation.- HIV
Associated
Immune
Exhaustion.- HIV
Cancers
in
Resource-Limited
Regions.- HIV
Compartments
and
Viral
Rebound
During
Treatment
Interruption.- HIV
Coreceptor
Tropism
in
Different
Reservoirs.- HIV
Counseling
and
Testing,
Prevention
of
HIV.- HIV
Funding
agencies
and
major
programs.- HIV
Infection,
Immune-based
Interventions
for.- HIV
Life
Cycle:
Overview.- HIV
Neurocognitive
Diagnosis,
Natural
History
and
Treatment.- HIV
Prevention
and
African
Americans.- HIV
Prevention
and
Asians
and
Pacific
Islanders.- HIV
Prevention
and
Hispanics.- HIV
Prevention
and
Labor
Migration.- HIV
Prevention
and
Women.- HIV
Prevention
Efforts
Within
Substance
Use
Disorder
Treatment
Settings.- HIV
Prevention
for
MSM.- HIV
Prevention
for
Serodiscordant
Couples.- HIV
Prevention
for
Stimulant
Using
Men
Who
have
Sex
with
Men.- HIV
Prevention
in
Persons
50
and
Older.- HIV
Prevention
in
the
Correctional
System.- HIV
Prevention
in
Transgender
Persons.- HIV
Prevention
in
Youth.- HIV
Reservoirs
in
Lymph
Nodes
and
Spleen.- HIV
Reservoirs
in
the
Central
Nervous
System.- HIV
Reservoirs
Within
the
Lungs.- HIV
Testing
and
Counseling.- HIV
Transmission
in
Female
Commercial
Sex
Workers
and
Host
Protective
Factors.- HIV-1
Assembly
Cofactors.- HIV-1
Maturation.- HIV-1
Mutational
Escape
from
Host
Immunity.- HIV-1
Pathogenesis
in
the
Gut.- HIV-1
Pre-Exposure
Prophylaxis.- HIV-1
Prevention
Using
Live-attenuated
Vaccines.- HIV-1
Rev
Expression
and
Functions.- HIV-1
Transmission
Blocking
Microbicides.- HIV-1
Transmission;
Influence
of
Bodily
Secretions.- HIV-1
Virion
Structure.- HIV-2
Diagnosis
and
Viral
Load
Measurements.- HIV-2
Envelope:
Structure,
Diversity
and
Evolution.- HIV-2
Infection
in
Europe, Epidemiology
of .- HIV-2
Infection:
The
Role
of
Immune
Activation
in
Pathogenesis.- HIV-2
Neurological
Manifestations.- HIV-2
Transmission.- HIV-2:
Lessons
from
the
Dakar
Cohort.- HIV-Associated
Cancers.- Hodgkin
Lymphoma
in
Patients
with
HIV
Infection.- Host
Genetics
and
Genomics.- Housing
as
HIV
Prevention.- Human
Papillomavirus
(HPV).- Identification
and
Validation
of
HIV
Cofactors.- Identifying
Opportunities
to
Block
HIV-1
Transmission
in
the
Female
Genital
Tract.- Immune
Activation
and
HIV
Transmission.- Immunogenetics
of
HIV-2
Infection.- Immunological
Responses
to
Antiretroviral
Therapy.- Immunology
of
Latent
HIV
Infection.- Immunopathogenesis
of
HIV
Co-infections.- Inflammasome
and
HIV.- Inflammatory
Cytokines.- Inhibition
of
HIV-1
Spread:
Cell-Free
Versus
Cell-Cell.- Initial
Antiretroviral
Regimens.- Integrase
Inhibitors.- Integration.- Integrin
Alpha4beta7.- Interactions
Between
HIV-2
and
Host
Restriction
Factors.- Kaposi's
Sarcoma-associated
Herpesvirus
(KSHV)
or
Human
Herpesvirus
8
(HHV-8).- KIR
Locus
Variation.- Latin
America
and
the
Caribbean,
specific
characteristics
of
HIV/AIDS
epidemic.- Leishmaniasis
and
HIV.- Long-Acting
Nanoformulated
Antiretroviral
Therapy.- Long-Term
Nonprogressors
and
Elite
Controllers.- Lung
Cancer.- M.
avium
Complex
and
Other
Nontuberculous
Mycobacteria
and
HIV.- Macrophages
in
HIV
Immunopathogenesis.- Macrophage-Specific
Aspects
of
HIV-1
Infection.- Male
Condoms.- Malignancies
in
Children
with
HIV
Infection.- Management
of
AIDS-related
Kaposi’s
Sarcoma.- Mass
Media
and
HIV
Prevention.- Maturation
Inhibitor.- Medical
male
circumcision,
infant
circumcision,
Prevention
of
HIV.- Men
who
have
sex
with
men
(MSM),
Epidemiology
of
HIV/AIDS.- Merkel
Cell
Carcinoma
and
Other
HIV-Associated
Skin
Cancers.- Merkel
Cell
Polyomavirus
(MCV).- MHC
Locus
Variation.- Microbial
Translocation.- Microfinance/Microenterprise
Approaches
to
HIV
Prevention.- Microsporidiosis.- Molecular
Biology
of
HIV-2.- Mother-to-Child
Transmission
of
HIV-1:
Role
of
Receptor
Usage
and
Target
Cells.- MTCT
HIV-1
Transmission
Update:
Transmission
Routes
&
Mechanisms.- Mucosal
Immunity
to
HIV-1.- Mucosal
Pathogenesis
in
SIV
Infection.- Multicentric
Castleman
Disease.- Multilevel
Interventions/Structural
Approaches
to
HIV
Prevention.- MX2
and
HIV-1
Restriction.- Natural
History
and
Clinical
Features
of
HIV-2
Infection.- Natural
Killer
Cells
and
Innate
Immunity
in
HIV-2
Infection.- Natural
Killer
Cells
and
their
Role
in
Preventing
HIV-1
Transmission.- Nef/Env/Vpu/Tetherin.- Network
Interventions.- NeuroAIDS
in
Resource-Poor
Settings,
Assessment,
and
Treatment
of.- Neuro-AIDS,
Immunopathogenesis
of.- Neurocognitive
Functioning
in
HIV
Substance
Users.- Neurocognitive
Outcomes
in
HIV-Infected
Children
and
Adolescents.- Neuroinflammation
and
HAND:
Therapeutic
Targeting.- Neuropsychological
testing
in
HIV
infected
individuals.- Neurotoxic
Consequences
of
Antiretroviral
Therapies.- NKT
Cells:
Bridging
Innate
and
Adaptive
Immunity.- Nonhuman
Primate
Models
of
HIV
Transmission.- Non-injecting
drug
users,
Epidemiology
of
HIV/AIDS.- Non-Neutralizing
Antibody
Responses
and
Protection
Against
HIV-1.- Non-Nucleoside
Reverse
Transcriptase
Inhibitors
for
Treatment
of
HIV
Infection.- Non-Pathogenic
SIV
Infection
of
Sooty
Mangabeys.- Nucleoside
and
Nucleotide
Reverse
Transcriptase
Inhibitors
(NRTIs).- Nuclear
Import:
HIV-1
Goes
NUPs.- Nurse-Delivered
Interventions
for
Adherence.- Origin
and
Distribution
of
HIV-1
Subtypes.- Other
HPV-Associated
Cancers
(Oropharyngeal
and
Penile).- Overcoming
the
Transcriptional
Block:
The
HIV-1
Tat
Auxiliary
Protein.- Overview
of
HIV
CNS
Infection.- Overview:
Immunopathogenesis.- Programmed
Death-1.- Peer-Based
Intervention
Approaches.- Phylogeographic
Insights
into
the
Origins
and
Epidemic
History
of
the
Human
Immunodeficiency
Virus
Type
2.- PIMT/TGS1.- PKR
and
HIV
Replication.- Plasmablastic
Lymphoma.- Pneumocystis
Jirovecii
Infection
and
HIV.- Positive
Health,
Dignity,
and
Prevention
(PHDP).- Post-treatment
Controllers.- Preexposure
Prophylaxis
(PrEP).- Pregnant
Women:
Care
and
Treatment.- Presentation
and
Pathogenesis
of
B-Cell
Lymphoid
Cancers
Associated
with
HIV
Infection.- Preventing
HIV-1
Transmission
Through
Vaccine-Induced
Immune
Responses.- Preventing
Mother-to-Child
Transmission
(PMTCT):
Prevention
of
HIV.- Preventing
Mother-to-Child
Transmission
of
HIV-1.- Prevention
clinical
trials
highlights
of
evidence
and
research.- Prevention
Counseling
and
Other
Strategies
in
the
HIV
Care
Setting.- Prevention
for
People
Living
with
HIV.- Prevention
of
Alcohol-Related
HIV
Risk
Behavior.- Prevention
of
Mother-to-Child
Transmission
of
AIDS.- Primary
Effusion
Lymphoma.- Prison
populations,
Epidemiology
of
HIV/AIDS.- Progressive
Multifocal
Leukoencephalopathy
and
HIV.- Protease
Inhibitor.- Pyroptosis
in
HIV
Infection:
HIV
Offense
Meets
a
Fiery
Host
Defense.- Recombinant
Forms
of
HIV-2.- Sexually
transmitted
infections
(STIs)
and
reproductive
track
infections
(RTIs),
care
and
treatment.- Retention
in
Care
Interventions.- Reverse
Transcriptase-Catalyzed
HIV-1
DNA
Synthesis.- Risk
of
Sexual
HIV-1
Transmission:
Co-infections
Associated
with
Risk.- Role
for
Histone
Deacetylase
1
and
Yin
Yang
1
Protein
(HDAC1:YY1)
in
Proviral
Latency.- Role
of
Antibodies
in
HIV
Transmission.- Role
of
Dendritic
Cells
in
HIV-2
Pathogenesis.- Role
of
LEDGF/p75
in
Cell
Biology
and
Disease
Pathogenesis.- Role
of
Regulatory
T
Cells
during
HIV
Infection.- Role
of
Transportin-SR2
(Transportin-3,
TRN-SR2,
TNPO3)
in
HIV
Replication.- Salmonellosis
and
other
bacterial
enteric
infections
and
HIV.- Sex
Work
and
HIV
Prevention.- Sexual
Risk
Factors
for
HIV
Exposure
and
Transmission.- SIV
Infection
in
Mandrills.- SIV
Infection
of
African
Green
Monkeys.- SIVmac
Infection
of
Macaques,
Immunopathogenesis
of.- SLX4
Complex
and
HIV
Replication.- South,
Southeast,
and
East
Asia,
specific
characteristics
of
HIV/AIDS
epidemic.- Stem
Cell
Transplantation.- Sub-Saharan
Africa,
specific
characteristics
of
HIV/AIDS
epidemic.- Surveillance
case
definition.- Systems
Biology.- T
Cell
Homeostasis.- T
Follicular
Helper
Cells
in
HIV
Infection.- T
memory
stem
cells.- Talaromyces
(Penicillium)
marneffei
and
HIV.- Tat
Expression
and
Function.- Th17
Cells.- The
Antibody
Response
to
HIV-2.- The
Cellular
Immune
Response
to
HIV-2
Infection.- Thymic
Function.- Tim-3.- Toxoplasmosis
in
HIV-Infected
Patients.- Transcription
(Initiation,
Regulation,
Elongation).- Translational
Interventions
(Intervention
Technology
Transfer).- Transmission
HIV-2:
Origin,
Epidemiology,
and
Phenotype.- Treatment
Failure
and
Resistance.- Treatment
of
Histoplasmosis,
Coccidioidomycosis,
and
Paracoccidioidomycosis
in
Patients
with
HIV
Infection.- TRIM
Protein
Family
and
Viral
Restriction.- TRIM5
Alpha
and
HIV-2
Infection.- TRIM5alpha.- Tropism
and
Properties
of
the
HIV-1
Envelope
Glycoprotein
in
Transmission.- Tuberculosis
and
HIV.- Uncoating
and
Nuclear
Entry.- Update
on
HIV-1
and
HIV-2
Dual
Infection.- Use
of
Technology
and
Social
Networking
in
HIV
Prevention.- Vaccine
Efforts
Against
AIDS.- Viral
Fitness
in
Hosts.- Viremic
Nonprogressors.- Virus
Assembly.- Virus-Host
Evolution
and
Positive
Selection.- Western
Europe,
North
America,
and
Australia/New
Zealand,
specific
characteristics
of
HIV/AIDS
epidemic.- Women,
Epidemiology
of
HIV/AIDS.
Notă biografică
Thomas
J.
Hope,
PH.D.
is
a
Professor
in
the
Departments
of
Cell
and
Molecular
Biology,
and
Obstetrics
and
Gynecology
in
the
Feinberg
School
of
Medicine,
and
in
Biomedical
Engineering
in
the
McCormick
School
of
Engineering
and
Applied
Sciences
at
Northwestern
University.
Dr.
Hope’s
laboratory
has
been
a
pioneer
in
the
use
of
cell
biology
approaches
to
study
HIV,
providing
images
and
movies
of
HIV
interacting
with
cells
and
tissues.
For
the
past
25
years,
his
research
has
focused
on
HIV
Cellular
Virology.
More
recently
this
focus
has
expanded
to
HIV-related
mucosal
immunology,
HIV
transmission,
and
HIV
Prevention
Science.
Douglas D. Richman, MD, is Distinguished Professor of Pathology and Medicine at the University of California, San Diego, and the Florence Seeley Riford Chair in AIDS Research. He is Director of the Center for AIDS Research at UC San Diego, Director of the UC San Diego AIDS Research Institute, and staff physician at the VA San Diego Healthcare System. Dr. Richman's laboratory, which was the first to identify HIV drug resistance, joined two others in identifying latently infected CD4 cells as the obstacle to eradication of HIV with potent antiretroviral therapy. His laboratory also described the dynamics of the neutralizing antibody response to HIV and the rapidity of viral escape and evolution in response to this selective pressure. The major current focus of Dr. Richman’s laboratory is the latent HIV reservoir and strategies to achieve eradication of this reservoir.
Mario Stevenson is Professor of Medicine and Chief of Infectious Diseases at the University of Miami Miller School of Medicine. For the past 30 years his research has focused on uncovering processes regulating the interplay between HIV-1 and its host, as well as mechanisms of viral persistence.
Douglas D. Richman, MD, is Distinguished Professor of Pathology and Medicine at the University of California, San Diego, and the Florence Seeley Riford Chair in AIDS Research. He is Director of the Center for AIDS Research at UC San Diego, Director of the UC San Diego AIDS Research Institute, and staff physician at the VA San Diego Healthcare System. Dr. Richman's laboratory, which was the first to identify HIV drug resistance, joined two others in identifying latently infected CD4 cells as the obstacle to eradication of HIV with potent antiretroviral therapy. His laboratory also described the dynamics of the neutralizing antibody response to HIV and the rapidity of viral escape and evolution in response to this selective pressure. The major current focus of Dr. Richman’s laboratory is the latent HIV reservoir and strategies to achieve eradication of this reservoir.
Mario Stevenson is Professor of Medicine and Chief of Infectious Diseases at the University of Miami Miller School of Medicine. For the past 30 years his research has focused on uncovering processes regulating the interplay between HIV-1 and its host, as well as mechanisms of viral persistence.
Textul de pe ultima copertă
For
the
first
time,
the
world’s
experts
in
HIV-AIDS
have
come
together
to
publish
the
Encyclopedia
of
AIDS.
The
work
features
over
4,000
A-Z
entries
including
medical,
cultural,
social,
and
pharmacological
essays.
The
Pathology
entries
cover
the
various
types
of
HIV-related
illnesses,
including
those
that
are
and
are
not
AIDS-defining.
Many
of
the
conditions
that
are
AIDS-defining
illnesses
have
their
own
entries
or
are
cross-referenced
to
a
generic
entry
in
which
several
related
conditions
are
discussed
(such
as
enteric
diseases
and
fungal
infections).
Typically,
the
treatment
of
any
given
form
of
pathology
is
briefly
discussed
in
the
entry
that
covers
that
illness.
The
reference
is
a
must-read
for
Infectious
Disease
specialists,
Immunologists,
Public
Health
researchers,
Virologists,
Microbiologists,
Pharmacologists,
and
Physicians.
Caracteristici
Features
over
280
A-Z
entries
including
medical,
cultural,
social,
and
pharmacological
essays
Covers various types of HIV-related illnesses
Entries contributed by world-experts in HIV-AIDS research
Covers various types of HIV-related illnesses
Entries contributed by world-experts in HIV-AIDS research